4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

509.09p
   
  • Change Today:
    -15.91p
  • 52 Week High: 790.00
  • 52 Week Low: 440.83
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 1
  • Market Cap: £79.11m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
15-Jun-26 RBC Capital Markets Outperform 525.00p 1,600.00p 1,400.00p Reiteration
02-Oct-25 RBC Capital Markets Outperform 775.00p 1,600.00p 1,600.00p Reiteration
13-Mar-25 RBC Capital Markets Outperform 1,115.00p - 1,600.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

4basebio Market Data

Currency UK Pounds
Share Price 509.09p
Change Today -15.91p
% Change -3.03 %
52 Week High 790.00
52 Week Low 440.83
Volume 1
Shares Issued 15.54m
Market Cap £79.11m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.32% below the market average49.32% below the market average49.32% below the market average49.32% below the market average49.32% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Price Trend
85.18% below the market average85.18% below the market average85.18% below the market average85.18% below the market average85.18% below the market average
53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average
Income Not Available
Growth
62.12% above the market average62.12% above the market average62.12% above the market average62.12% above the market average62.12% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

4basebio Dividends

No dividends found

Trades for 22-Oct-2026

Time Volume / Share Price
08:31 1 @ 525.30p

4basebio Key Personnel

CFO David John Roth
CEO Amy Walker
COO Scott Lorimer

Top of Page